CONMED Corporation (FRA:EC8)
Germany flag Germany · Delayed Price · Currency is EUR
34.20
-0.20 (-0.58%)
Last updated: Jan 27, 2026, 8:10 AM CET

CONMED Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,3751,3071,2451,0451,011
Revenue Growth (YoY)
5.18%5.00%19.06%3.45%17.18%
Cost of Revenue
589.55573.98559.9469.73442.6
Gross Profit
785.17733.03684.85575.75568.04
Selling, General & Admin
539.08519.33504.66441.42414.73
Research & Development
55.8854.4352.647.1543.57
Operating Expenses
594.97573.75557.26488.57458.29
Operating Income
190.21159.28127.5887.17109.74
Interest Expense
-31.09-37.3-39.78-28.91-35.49
Other Non Operating Income (Expenses)
-----0.05
EBT Excluding Unusual Items
159.12121.9887.8158.2774.21
Merger & Restructuring Charges
-49.86--9.4-14.6-
Legal Settlements
-2.61----
Other Unusual Items
-35.5341.052.42-114.53-1.1
Pretax Income
71.12163.0380.83-70.8673.11
Income Tax Expense
24.0630.6116.379.7210.56
Net Income
47.06132.4264.46-80.5862.54
Net Income to Common
47.06132.4264.46-80.5862.54
Net Income Growth
-64.47%105.44%--557.16%
Shares Outstanding (Basic)
3131313029
Shares Outstanding (Diluted)
3131323032
Shares Change (YoY)
-0.00%-1.26%5.02%-6.75%9.34%
EPS (Basic)
1.524.292.10-2.682.14
EPS (Diluted)
1.514.252.04-2.681.94
EPS Growth
-64.47%108.33%--506.25%
Free Cash Flow
-153.88106.3211.5896.9
Free Cash Flow Per Share
-4.943.370.393.01
Dividend Per Share
0.6000.8000.8000.8000.800
Dividend Growth
-25.00%----
Gross Margin
57.12%56.08%55.02%55.07%56.21%
Operating Margin
13.84%12.19%10.25%8.34%10.86%
Profit Margin
3.42%10.13%5.18%-7.71%6.19%
Free Cash Flow Margin
-11.77%8.54%1.11%9.59%
EBITDA
264.11229.74197.76154.59177.19
EBITDA Margin
19.21%17.58%15.89%14.79%17.53%
D&A For EBITDA
73.9170.4670.1767.4267.44
EBIT
190.21159.28127.5887.17109.74
EBIT Margin
13.84%12.19%10.25%8.34%10.86%
Effective Tax Rate
33.83%18.77%20.25%-14.45%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.